drugset / Trial / NCT07275359

Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations

NCT07275359

Phase 1 Not yet recruiting 45 enrolled Duke University National Institute on Aging (NIA) · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the safety and tolerability of Metformin and how it changes blood markers associated with aging in persons who have chronic obstructive pulmonary disease (COPD) who do not have diabetes.

Timeline

Start
2026-09-01
Primary completion
2028-09-01
Completion
2029-10-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule